Mobocertinib is a special treatment for NSCLC. It targets EGFR mutations. These mutations are usually found in the 20th exon and are common in people with NSCLC across the globe.
It blocks the EGFR so that cancer cells don’t grow out of control and divide uncontrollably. Mobocertinib comes in 40 mg capsule form. The usual dose is 160 mg a day, you can take it with or without food.
It comes in bottles with 90 capsules each.
Reviews
There are no reviews yet.